David Hoang

Stock Analyst at Deutsche Bank

(2.02)
# 3,132
Out of 5,044 analysts
46
Total ratings
38.89%
Success rate
-2.87%
Average return

Stocks Rated by David Hoang

Praxis Precision Medicines
Oct 17, 2025
Maintains: Buy
Price Target: $65$280
Current: $199.33
Upside: +40.47%
Spyre Therapeutics
Sep 26, 2025
Initiates: Buy
Price Target: $43
Current: $24.64
Upside: +74.51%
Harmony Biosciences Holdings
Sep 25, 2025
Maintains: Buy
Price Target: $54$36
Current: $29.64
Upside: +21.46%
Sarepta Therapeutics
Aug 15, 2025
Maintains: Sell
Price Target: $6$12
Current: $24.22
Upside: -50.45%
ACADIA Pharmaceuticals
May 21, 2025
Upgrades: Buy
Price Target: $20$35
Current: $22.62
Upside: +54.73%
Alkermes
Mar 27, 2025
Maintains: Buy
Price Target: $40$52
Current: $31.00
Upside: +67.74%
Xenon Pharmaceuticals
Feb 11, 2025
Initiates: Buy
Price Target: $67
Current: $42.53
Upside: +57.54%
Denali Therapeutics
Feb 11, 2025
Initiates: Buy
Price Target: $31
Current: $16.92
Upside: +83.22%
Biohaven
Feb 11, 2025
Initiates: Buy
Price Target: $65
Current: $17.20
Upside: +277.91%
Axsome Therapeutics
Feb 11, 2025
Initiates: Buy
Price Target: $176
Current: $133.51
Upside: +31.83%
Initiates: Buy
Price Target: $12
Current: $18.59
Upside: -35.45%
Maintains: Neutral
Price Target: $150$158
Current: $147.38
Upside: +7.21%
Initiates: Buy
Price Target: $7
Current: $2.29
Upside: +205.68%
Initiates: Buy
Price Target: $16
Current: $5.92
Upside: +170.27%
Initiates: Buy
Price Target: $16
Current: $4.66
Upside: +243.35%
Initiates: Neutral
Price Target: $220
Current: $475.91
Upside: -53.77%
Initiates: Outperform
Price Target: $80
Current: $39.55
Upside: +102.28%
Downgrades: Neutral
Price Target: $3
Current: $2.38
Upside: +26.05%